Tacloban, Bb Girl .
HRN: 28-02-57 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/04/2025
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
11/04/2025
11/11/2025
IVTT
45mg
Q24h
PSNB
Checking Final Appropriateness
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes